Absolute Quantification of Four Isoforms of the Class I Phosphoinositide-3-kinase Catalytic Subunit by Real-Time RT-PCR(Communications to the Editor)

    • NAKAMURA Hiroyuki
    • Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research : Division of Gastroenterological Surgery, Department of Surgery, Tohoku University School of Medicine
    • DAN Shingo
    • Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
    • AKASHI Tetsuyuki
    • Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
    • UNNO Michiaki
    • Division of Gastroenterological Surgery, Department of Surgery, Tohoku University School of Medicine

    • YAMORI Takao
    • Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research

Abstract

Class I phosphoinositide-3-kinase (PI3K) consists of four isoforms of the catalytic subunit, p110α, -β, -δ and -γ, generated from the genes PIK3CA, -B, -D and -G, respectively. These isoforms show different tissue distribution and some specific and indispensable functions in various biological pathways such as development, inflammation, autoimmunity and malignancy. In human cancers, frequent genomic amplification and gain-of-function mutations of PIK3CA were reported, which suggests an oncogenic potential. However, the role played by the other three isoforms in human cancer remains to be determined. We wanted to investigate the relationship between all the isoforms in human cancers. Here, we have established a system for the simultaneous absolute-quantification of all four isoforms by realtime reverse transcription polymerase chain reaction (RT-PCR). The reliability of this system was confirmed using three main criteria: (i) good correlation of each standard curve, (ii) high specificity of the PCR reactions and (iii) excellent reproducibility. Using this system, we investigated human monocytic leukemia cells (U937) to analyze expression of all four isoforms. The biological implications of the expression level of the four isoforms of class I PI3K catalytic subunit are discussed.

Journal

Biological & pharmaceutical bulletin   [List of Volumes]

Biological & pharmaceutical bulletin 30(6), 1181-1184, 2007-06-01  [Table of Contents]

The Pharmaceutical Society of Japan

References:  44

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110006278417
  • NII NACSIS-CAT ID (NCID) :
    AA10885497
  • Text Lang :
    ENG
  • Article Type :
    SHO
  • ISSN :
    09186158
  • NDL Article ID :
    8741651
  • NDL Source Classification :
    ZS51(科学技術--薬学)
  • NDL Call No. :
    Z53-V41
  • Databases :
    CJP  NDL  NII-ELS  J-STAGE